Prof Jean-Christophe Leroux is a Full Professor of Drug Formulation and Delivery at the Institute of Pharmaceutical Sciences (IPW) at ETH Zurich. He trained as a pharmacist at the Université de Montréal, Canada, obtained his PhD in pharmaceutical sciences from the University of Geneva and worked as a postdoctoral fellow at the University of California, San Francisco, USA. He was a Professor of Pharmaceutical Technology at the Université de Montréal from 1997 to 2008. Prof Leroux has made important fundamental and applied contributions to the fields of biomaterials and drug delivery and has also been involved in the development of innovative bio-detoxification systems. He has published more than 260 peer-reviewed research articles and book chapters and is the (co)inventor of 25 original patents and patent applications. He is a fellow of the AAPS, EurAsc and the CRS and is the co-founder of Versantis AG and Inositec AG, two ETH Zurich spin-off pharmaceutical companies developing drugs for the treatment of hepatic encephalopathy/urea cycle disorders and vascular/kidney calcification respectively.